{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T15:43:33Z","timestamp":1787672613550,"version":"build-2736575974"},"reference-count":61,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Rheumatic Disease Clinics of North America"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1016\/j.rdc.2013.02.013","type":"journal-article","created":{"date-parts":[[2013,3,16]],"date-time":"2013-03-16T08:16:33Z","timestamp":1363421793000},"page":"347-364","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Localized Cutaneous Fibrosing Disorders"],"prefix":"10.1016","volume":"39","author":[{"given":"Aaliya","family":"Yaqub","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorinda","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerri E.","family":"Rieger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David F.","family":"Fiorentino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.rdc.2013.02.013_bib1","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/00005792-199409000-00002","article-title":"Internal involvement in localized scleroderma","volume":"73","author":"Dehen","year":"1994","journal-title":"Medicine"},{"issue":"9","key":"10.1016\/j.rdc.2013.02.013_bib2","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1002\/art.21264","article-title":"Localized scleroderma in childhood is not just a skin disease","volume":"52","author":"Zulian","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.rdc.2013.02.013_bib3","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jaad.2010.05.045","article-title":"Update on morphea: part I. Epidemiology, clinical presentation, and pathogenesis","volume":"64","author":"Fett","year":"2011","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.rdc.2013.02.013_bib4","first-page":"73","article-title":"The epidemiology of morphea (localized scleroderma) in Olmsted County 1960-1993","volume":"24","author":"Peterson","year":"1997","journal-title":"J\u00a0Rheumatol"},{"issue":"3","key":"10.1016\/j.rdc.2013.02.013_bib5","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0889-857X(02)00010-8","article-title":"Scleroderma in children and adolescents","volume":"28","author":"Murray","year":"2002","journal-title":"Rheum Dis Clin North Am"},{"issue":"5","key":"10.1016\/j.rdc.2013.02.013_bib6","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1093\/rheumatology\/kei251","article-title":"Juvenile localized scleroderma: clinical and epidemiological features in 750 children. An international study","volume":"45","author":"Zulian","year":"2006","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"10.1016\/j.rdc.2013.02.013_bib7","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jaad.2008.05.005","article-title":"Pediatric morphea (localized scleroderma): review of 136 patients","volume":"59","author":"Christen-Zaech","year":"2008","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.rdc.2013.02.013_bib8","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1001\/archdermatol.2009.79","article-title":"Distinct autoimmune syndromes in morphea: a review of 245 adult and pediatric cases","volume":"145","author":"Leitenberger","year":"2009","journal-title":"Arch Dermatol"},{"issue":"11","key":"10.1016\/j.rdc.2013.02.013_bib9","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.4065\/70.11.1068","article-title":"Classification of morphea (localized scleroderma)","volume":"70","author":"Peterson","year":"1995","journal-title":"Mayo Clin Proc"},{"issue":"6","key":"10.1016\/j.rdc.2013.02.013_bib10","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1097\/01.bor.0000245727.40630.c3","article-title":"Localized scleroderma","volume":"18","author":"Laxer","year":"2006","journal-title":"Curr Opin Rheumatol"},{"issue":"Suppl 6","key":"10.1016\/j.rdc.2013.02.013_bib11","first-page":"S1","article-title":"AWMF Guideline no. 013\/066. Diagnosis and therapy of circumscribed scleroderma","volume":"7","author":"Kreuter","year":"2009","journal-title":"J\u00a0Dtsch Dermatol Ges"},{"issue":"2","key":"10.1016\/j.rdc.2013.02.013_bib12","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1529-8019.2012.01479.x","article-title":"Localized scleroderma","volume":"25","author":"Kreuter","year":"2012","journal-title":"Dermatol Ther"},{"issue":"3","key":"10.1016\/j.rdc.2013.02.013_bib13","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0190-9622(94)70053-2","article-title":"Atrophoderma of Pasini and Pierini. Clinical and histopathologic findings and antibodies to Borrelia burgdorferi in thirty-four patients","volume":"30","author":"Buechner","year":"1994","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"12","key":"10.1016\/j.rdc.2013.02.013_bib14","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1111\/j.1600-0560.2008.00986.x","article-title":"Atrophoderma of Pasini and Pierini: a clinical and histopathological study","volume":"35","author":"Saleh","year":"2008","journal-title":"J\u00a0Cutan Pathol"},{"issue":"4","key":"10.1016\/j.rdc.2013.02.013_bib15","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1365-4362.1990.tb02562.x","article-title":"Concomitant unilateral idiopathic atrophoderma of Pasini and Pierini (IAPP) and morphea. Observations supporting IAPP as a variant of morphea","volume":"29","author":"Murphy","year":"1990","journal-title":"Int J Dermatol"},{"issue":"2","key":"10.1016\/j.rdc.2013.02.013_bib16","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1067\/S0190-9622(03)00429-8","article-title":"Superficial morphea","volume":"49","author":"Jacobson","year":"2003","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.rdc.2013.02.013_bib17","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.jaad.2003.11.088","article-title":"Is superficial morphea synonymous with atrophoderma Pasini-Pierini?","volume":"50","author":"Jablonska","year":"2004","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.rdc.2013.02.013_bib18","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1742-1241.2006.01039.x","article-title":"Disabling pansclerotic morphoea: a case report","volume":"64","author":"Tekin","year":"2010","journal-title":"Int J Clin Pract"},{"issue":"4","key":"10.1016\/j.rdc.2013.02.013_bib19","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.berh.2012.08.001","article-title":"Eosinophilic fasciitis (Shulman disease)","volume":"26","author":"Lebeaux","year":"2012","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"4","key":"10.1016\/j.rdc.2013.02.013_bib20","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1046\/j.1468-3083.2002.00442.x","article-title":"Scleroderma \u2018en coup de sabre\u2019 and progressive facial hemiatrophy. Is it possible to differentiate them?","volume":"16","author":"Orozco-Covarrubias","year":"2002","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"9","key":"10.1016\/j.rdc.2013.02.013_bib21","first-page":"1997","article-title":"Progressive facial hemiatrophy: central nervous system involvement and relationship with scleroderma en coup de sabre","volume":"30","author":"Blaszczyk","year":"2003","journal-title":"J\u00a0Rheumatol"},{"issue":"5","key":"10.1016\/j.rdc.2013.02.013_bib22","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1525-1470.2006.00289.x","article-title":"Deep morphea after vaccination in two young children","volume":"23","author":"Torrelo","year":"2006","journal-title":"Pediatr Dermatol"},{"issue":"9","key":"10.1016\/j.rdc.2013.02.013_bib23","first-page":"1252","article-title":"Vitamin B12-associated localized scleroderma and its treatment","volume":"30","author":"Ho","year":"2004","journal-title":"Dermatol Surg"},{"issue":"1","key":"10.1016\/j.rdc.2013.02.013_bib24","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jaad.2008.03.009","article-title":"Drug-induced morphea: report of a case induced by balicatib and review of the literature","volume":"59","author":"Peroni","year":"2008","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.rdc.2013.02.013_bib25","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0738-081X(98)00006-6","article-title":"Drug-induced scleroderma and sclerodermiform conditions","volume":"16","author":"Haustein","year":"1998","journal-title":"Clin Dermatol"},{"issue":"6","key":"10.1016\/j.rdc.2013.02.013_bib26","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1111\/j.1365-2133.2004.05969.x","article-title":"A\u00a0case of peplomycin-induced scleroderma","volume":"150","author":"Asano","year":"2004","journal-title":"Br J Dermatol"},{"issue":"8","key":"10.1016\/j.rdc.2013.02.013_bib27","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.clinthera.2006.08.004","article-title":"A\u00a0review of the receptor-binding and pharmacokinetic properties of dopamine agonists","volume":"28","author":"Kvernmo","year":"2006","journal-title":"Clin Ther"},{"issue":"11","key":"10.1016\/j.rdc.2013.02.013_bib28","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1136\/ard.48.11.963","article-title":"Development of morphoea in rheumatoid arthritis treated with penicillamine","volume":"48","author":"Liddle","year":"1989","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.rdc.2013.02.013_bib29","doi-asserted-by":"crossref","first-page":"e89","DOI":"10.1016\/j.jaad.2010.11.033","article-title":"Morphea-like skin reactions in patients treated with the cathepsin K inhibitor balicatib","volume":"66","author":"Runger","year":"2012","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.rdc.2013.02.013_bib30","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1080\/19338244.2011.564231","article-title":"Pesticide-induced scleroderma and early intensive immunosuppressive treatment","volume":"67","author":"Sozeri","year":"2012","journal-title":"Arch Environ Occup Health"},{"issue":"1","key":"10.1016\/j.rdc.2013.02.013_bib31","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s00420-003-0462-5","article-title":"A\u00a0case-control study of occupational exposures and systemic sclerosis","volume":"77","author":"Bovenzi","year":"2004","journal-title":"Int Arch Occup Environ Health"},{"issue":"6","key":"10.1016\/j.rdc.2013.02.013_bib32","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1002\/1529-0131(199806)41:6<1111::AID-ART19>3.0.CO;2-J","article-title":"Is occupational organic solvent exposure a risk factor for scleroderma?","volume":"41","author":"Nietert","year":"1998","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.rdc.2013.02.013_bib33","first-page":"256","article-title":"Scleroderma-like lesions and Parkinson's disease: possible links with exposure to pesticides","volume":"17","author":"Stinco","year":"2007","journal-title":"Eur J Dermatol"},{"issue":"9","key":"10.1016\/j.rdc.2013.02.013_bib34","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s00066-009-2051-3","article-title":"Localized morphea\u2014a rare but significant secondary complication following breast cancer radiotherapy. Case report and review of the literature on radiation reaction among patients with scleroderma\/morphea","volume":"185","author":"Herrmann","year":"2009","journal-title":"Strahlenther Onkol"},{"issue":"6","key":"10.1016\/j.rdc.2013.02.013_bib35","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/S0190-9622(96)90116-4","article-title":"Localized scleroderma in breast cancer patients treated with supervoltage external beam radiation: radiation port scleroderma","volume":"35","author":"Davis","year":"1996","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.rdc.2013.02.013_bib36","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1046\/j.1440-0960.1999.00330.x","article-title":"Radiation-induced localized scleroderma in breast cancer patients","volume":"40","author":"Bleasel","year":"1999","journal-title":"Australas J Dermatol"},{"issue":"1","key":"10.1016\/j.rdc.2013.02.013_bib37","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1159\/000018322","article-title":"Postirradiation morphea of the breast presentation of two cases and review of the literature","volume":"200","author":"Schaffer","year":"2000","journal-title":"Dermatology"},{"key":"10.1016\/j.rdc.2013.02.013_bib38","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/1752-1947-2-136","article-title":"Radiation-induced morphea of the breast: a case report","volume":"2","author":"Cheah","year":"2008","journal-title":"J\u00a0Med Case Rep"},{"issue":"1","key":"10.1016\/j.rdc.2013.02.013_bib39","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000330324","article-title":"Irradiation-induced morphea: x-rays as triggers of autoimmunity","volume":"223","author":"Laetsch","year":"2011","journal-title":"Dermatology"},{"issue":"5","key":"10.1016\/j.rdc.2013.02.013_bib40","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.jaad.2010.09.006","article-title":"A\u00a0systematic review of morphea treatments and therapeutic algorithm","volume":"65","author":"Zwischenberger","year":"2011","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"11","key":"10.1016\/j.rdc.2013.02.013_bib41","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1093\/rheumatology\/kep244","article-title":"Successful treatment of severe or methotrexate-resistant juvenile localized scleroderma with mycophenolate mofetil","volume":"48","author":"Martini","year":"2009","journal-title":"Rheumatology"},{"issue":"5\u00a0Pt 1","key":"10.1016\/j.rdc.2013.02.013_bib42","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S1262-3636(07)70307-5","article-title":"Scleredema adultorum of Buschke: an under recognized skin complication of diabetes","volume":"32","author":"Meguerditchian","year":"2006","journal-title":"Diabetes Metab"},{"issue":"6","key":"10.1016\/j.rdc.2013.02.013_bib43","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.semarthrit.2006.01.004","article-title":"Scleredema adultorum of Buschke: a case report and review of the literature","volume":"35","author":"Beers","year":"2006","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.rdc.2013.02.013_bib44","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s10067-004-1076-3","article-title":"From scleredema to AL amyloidosis: disease progression or coincidence? Review of the literature","volume":"25","author":"Dziadzio","year":"2006","journal-title":"Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.rdc.2013.02.013_bib45","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s11926-011-0220-8","article-title":"Scleroderma mimics","volume":"14","author":"Nashel","year":"2012","journal-title":"Curr Rheumatol Rep"},{"issue":"12","key":"10.1016\/j.rdc.2013.02.013_bib46","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s00066-004-1286-2","article-title":"Radiotherapy of benign diseases\u2014scleredema adultorum Buschke","volume":"180","author":"Konemann","year":"2004","journal-title":"Strahlenther Onkol"},{"issue":"12","key":"10.1016\/j.rdc.2013.02.013_bib47","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.3899\/jrheum.100561","article-title":"Treatment of scleredema diabeticorum with tamoxifen","volume":"37","author":"Alsaeedi","year":"2010","journal-title":"J\u00a0Rheumatol"},{"issue":"3","key":"10.1016\/j.rdc.2013.02.013_bib48","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0733-8635(02)00017-7","article-title":"Diffuse cutaneous mucinoses","volume":"20","author":"Jackson","year":"2002","journal-title":"Dermatol Clin"},{"issue":"5","key":"10.1016\/j.rdc.2013.02.013_bib49","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/j.1600-0560.2012.01882.x","article-title":"Scleromyxedema and the dermato-neuro syndrome: case report and review of the literature","volume":"39","author":"Fleming","year":"2012","journal-title":"J\u00a0Cutan Pathol"},{"issue":"3","key":"10.1016\/j.rdc.2013.02.013_bib50","first-page":"263","article-title":"Intravenous immunoglobulin therapy for scleromyxedema: a case report and review of literature","volume":"9","author":"Sroa","year":"2010","journal-title":"J\u00a0Drugs Dermatol"},{"issue":"3","key":"10.1016\/j.rdc.2013.02.013_bib51","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.semarthrit.2007.10.015","article-title":"Intravenous gammaglobulin and thalidomide may be an effective therapeutic combination in refractory scleromyxedema: case report and discussion of the literature","volume":"38","author":"Efthimiou","year":"2008","journal-title":"Semin Arthritis Rheum"},{"issue":"9234","key":"10.1016\/j.rdc.2013.02.013_bib52","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/S0140-6736(00)02694-5","article-title":"Scleromyxoedema-like cutaneous diseases in renal-dialysis patients","volume":"356","author":"Cowper","year":"2000","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.rdc.2013.02.013_bib53","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.berh.2012.07.008","article-title":"Nephrogenic systemic fibrosis: a systemic fibrosing disease resulting from gadolinium exposure","volume":"26","author":"Bernstein","year":"2012","journal-title":"Best practice & research. Clinical rheumatology"},{"issue":"6","key":"10.1016\/j.rdc.2013.02.013_bib54","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.jaad.2010.08.041","article-title":"Nephrogenic systemic fibrosis: clinicopathological definition and workup recommendations","volume":"65","author":"Girardi","year":"2011","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"8","key":"10.1016\/j.rdc.2013.02.013_bib55","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1002\/art.23696","article-title":"Imatinib mesylate treatment of nephrogenic systemic fibrosis","volume":"58","author":"Kay","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.rdc.2013.02.013_bib56","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1093\/ndt\/gfq693","article-title":"Renal transplantation for nephrogenic systemic fibrosis: a case report and review of the literature","volume":"26","author":"Cuffy","year":"2011","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"10.1016\/j.rdc.2013.02.013_bib57","doi-asserted-by":"crossref","first-page":"515.e1","DOI":"10.1016\/j.jaad.2011.11.960","article-title":"Graft-versus-host disease: part I. Pathogenesis and clinical manifestations of graft-versus-host disease","volume":"66","author":"Hymes","year":"2012","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.rdc.2013.02.013_bib58","doi-asserted-by":"crossref","first-page":"535.e1","DOI":"10.1016\/j.jaad.2011.11.961","article-title":"Graft-versus-host disease: part II. Management of cutaneous graft-versus-host disease","volume":"66","author":"Hymes","year":"2012","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"15","key":"10.1016\/j.rdc.2013.02.013_bib59","doi-asserted-by":"crossref","first-page":"4070","DOI":"10.1182\/blood-2011-03-341693","article-title":"A\u00a0phase 1 study of imatinib for corticosteroid-dependent\/refractory chronic graft-versus-host disease: response does not correlate with anti-PDGFRA antibodies","volume":"118","author":"Chen","year":"2011","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.rdc.2013.02.013_bib60","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1182\/blood-2009-02-204750","article-title":"Imatinib mesylate as salvage therapy for refractory sclerotic chronic graft-versus-host disease","volume":"114","author":"Magro","year":"2009","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.rdc.2013.02.013_bib61","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1182\/blood-2009-02-204156","article-title":"Imatinib for refractory chronic graft-versus-host disease with fibrotic features","volume":"114","author":"Olivieri","year":"2009","journal-title":"Blood"}],"container-title":["Rheumatic Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X13000148?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X13000148?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T11:11:40Z","timestamp":1760181100000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889857X13000148"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":61,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S0889857X13000148"],"URL":"https:\/\/doi.org\/10.1016\/j.rdc.2013.02.013","relation":{},"ISSN":["0889-857X"],"issn-type":[{"value":"0889-857X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Localized Cutaneous Fibrosing Disorders","name":"articletitle","label":"Article Title"},{"value":"Rheumatic Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rdc.2013.02.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}